Phaarmasia

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE486I01016
  • NSEID:
  • BSEID: 523620
INR
92.00
0.00 (0.00%)
BSENSE

Oct 08

BSE+NSE Vol: 3

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Sunil Healthcare
Phaarmasia
Vineet Laborator
Source Natural
Ajooni Biotech
ANG Lifesciences
Biofil Chemicals
Mangalam Drugs
Shelter Pharma
Cian Healthcare
Onyx Biotec
Why is Phaarmasia Ltd ?
1
Weak Long Term Fundamental Strength with a 21.34% CAGR growth in Operating Profits over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.99
  • The company has reported losses. Due to this company has reported negative ROCE
2
With a growth in Net Profit of 835.06%, the company declared Very Positive results in Dec 25
  • The company has declared positive results for the last 2 consecutive quarters
  • NET SALES(Latest six months) Higher at Rs 32.60 cr
  • PAT(Latest six months) Higher at Rs 2.48 cr
  • ROCE(HY) Highest at 7.91%
3
Stock is technically in a Mildly Bullish range
  • The stocks MACD and KST technical factors are also Bullish
4
With ROE of 20.7, it has a Very Attractive valuation with a 4.9 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 169.92%, its profits have risen by 281% ; the PEG ratio of the company is 0.1
5
Majority shareholders : Promoters
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Phaarmasia for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Phaarmasia
194.31%
2.10
80.88%
Sensex
-11.86%
-0.50
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
21.27%
EBIT Growth (5y)
25.15%
EBIT to Interest (avg)
-1.15
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
2.35
Tax Ratio
17.49%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
-10.15%
ROE (avg)
1.86%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
30
Industry P/E
37
Price to Book Value
2.84
EV to EBIT
32.28
EV to EBITDA
29.09
EV to Capital Employed
4.33
EV to Sales
1.09
PEG Ratio
0.13
Dividend Yield
NA
ROCE (Latest)
ROE (Latest)
9.60%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
NET SALES(Latest six months)

At Rs 16.01 cr has Grown at 30.16%

-6What is not working for the Company
NET SALES(Q)

At Rs 8.28 cr has Fallen at -29.8% (vs previous 4Q average

PAT(Q)

At Rs 0.34 cr has Fallen at -33.7% (vs previous 4Q average

Loading Valuation Snapshot...
Here's what is not working for Phaarmasia
Net Sales - Quarterly
At Rs 8.28 cr has Fallen at -29.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 11.80 Cr
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 0.34 cr has Fallen at -33.7% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 0.51 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)